These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16181509)

  • 1. Influence of age and carriage status on salivary IgA to Neisseria meningitidis.
    Horton RE; Stuart J; Christensen H; Borrow R; Guthrie T; Davenport V; Finn A; Williams NA; Heyderman RS;
    Epidemiol Infect; 2005 Oct; 133(5):883-9. PubMed ID: 16181509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carriage of Neisseria meningitidis in Europe: a review of studies undertaken in the region.
    Soriano-Gabarró M; Wolter J; Hogea C; Vyse A
    Expert Rev Anti Infect Ther; 2011 Sep; 9(9):761-74. PubMed ID: 21905785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasopharyngeal carriage of Neisseria meningitidis in general population and meningococcal disease.
    Ichhpujani RL; Mohan R; Grover SS; Joshi PR; Kumari S
    J Commun Dis; 1990 Dec; 22(4):264-8. PubMed ID: 2129123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasopharyngeal carriage of Neisseria meningitidis in the contacts of index cases of meningococcal meningitis.
    Ichhpujani RL; Singh T; Kumari S; Basu RN
    J Commun Dis; 1986 Mar; 18(1):1-5. PubMed ID: 3091676
    [No Abstract]   [Full Text] [Related]  

  • 6. Genotype-specific carriage of Neisseria meningitidis in Georgia counties with hyper- and hyposporadic rates of meningococcal disease.
    Kellerman SE; McCombs K; Ray M; Baughman W; Reeves MW; Popovic T; Rosenstein NE; Farley MM; Blake P; Stephens DS;
    J Infect Dis; 2002 Jul; 186(1):40-8. PubMed ID: 12089660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neisseria meningitidis B vaccines.
    Panatto D; Amicizia D; Lai PL; Gasparini R
    Expert Rev Vaccines; 2011 Sep; 10(9):1337-51. PubMed ID: 21919622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in Neisseria meningitidis carriage by socioeconomic status: a cross-sectional study.
    Cleary PR; Calvert N; Gee S; Graham C; Gray S; Kaczmarski E; Morphet J; Murphy L; Verlander N; Wood T; Borrow R
    J Public Health (Oxf); 2016 Mar; 38(1):61-70. PubMed ID: 25742719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing epidemiology of meningococcal invasive disease in the Czech republic caused by new clone Neisseria meningitidis C:2a:P1.2(P1.5), ET-15/37.
    Krizova P; Musilek M
    Cent Eur J Public Health; 1995 Nov; 3(4):189-94. PubMed ID: 8903519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity.
    Mueller JE; Yaro S; Njanpop-Lafourcade BM; Drabo A; Idohou RS; Kroman SS; Sanou O; Diagbouga S; Traoré Y; Sangaré L; Borrow R; Gessner BD
    J Infect Dis; 2011 Dec; 204(11):1787-95. PubMed ID: 21998478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The multicomponent meningococcal serogroup B vaccine (4CMenB): origin, composition, health impact and unknown aspects.
    Mameli C; Galli E; Mantegazza C; Fabiano V; Zuccotti GV
    Future Microbiol; 2015; 10(10):1579-98. PubMed ID: 26437903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England.
    Trotter C; Findlow J; Balmer P; Holland A; Barchha R; Hamer N; Andrews N; Miller E; Borrow R
    Clin Vaccine Immunol; 2007 Jul; 14(7):863-8. PubMed ID: 17494636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination against serogroup B Neisseria meningitidis: Perceptions and attitudes of parents.
    Le Ngoc Tho S; Ader F; Ferry T; Floret D; Arnal M; Fargeas S; Chidiac C; Valour F
    Vaccine; 2015 Jul; 33(30):3463-70. PubMed ID: 26055293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methods for analyzing the frequency, prevalence and the duration of asymptomatic carriage of Neisseria meningitidis. Longitudinal study of a school population in Belgium].
    De Wals P; Gilquin C; De Maeyer S
    Med Trop (Mars); 1982; 42(5):537-43. PubMed ID: 6818415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meningococcal B Vaccination (4CMenB) in Infants and Toddlers.
    Esposito S; Tagliabue C; Bosis S
    J Immunol Res; 2015; 2015():402381. PubMed ID: 26351647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of immunity after a major serogroup W-135 meningococcal disease epidemic, Burkina Faso, 2002.
    Raghunathan PL; Jones JD; Tiendrebéogo SR; Sanou I; Sangaré L; Kouanda S; Dabal M; Lingani C; Elie CM; Johnson S; Ari M; Martinez J; Chatt J; Sidibe K; Schmink S; Mayer LW; Kondé MK; Djingarey MH; Popovic T; Plikaytis BD; Carlone GM; Rosenstein N; Soriano-Gabarró M
    J Infect Dis; 2006 Mar; 193(5):607-16. PubMed ID: 16453255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal carriage and immunity in western Burkina Faso, 2003.
    Yaro S; Traoré Y; Tarnagda Z; Sangaré L; NjanpopLafourcade BM; Drabo A; Findlow H; Borrow R; Nicolas P; Gessner BD; Mueller JE
    Vaccine; 2007 Sep; 25 Suppl 1():A42-6. PubMed ID: 17559988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease.
    Olsen SF; Djurhuus B; Rasmussen K; Joensen HD; Larsen SO; Zoffman H; Lind I
    Epidemiol Infect; 1991 Jun; 106(3):445-57. PubMed ID: 1904825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neisseria meningitidis B vaccines: recent advances and possible immunization policies.
    Gasparini R; Amicizia D; Domnich A; Lai PL; Panatto D
    Expert Rev Vaccines; 2014 Mar; 13(3):345-64. PubMed ID: 24476428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
    Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R;
    Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.